ClearPoint Neuro CLPT Institutional Ownership

Updated Oct 30, 2026

ClearPoint Neuro, Inc. (NASDAQ:CLPT) counted 130 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• These investors held 45.55% of ClearPoint Neuro's outstanding shares at the end of Q2 2026, up from 43.32% in Q1 2026.
• Total shares held in ClearPoint Neuro rose 6.96% from Q1 2026, while the number of holders rose 38.30% from Q2 2025.
• Of the 130 holders, 71 added to their positions, 30 reduced their stakes and 29 left their positions unchanged in Q2 2026.
• The aggregate institutional position in ClearPoint Neuro was 13.9Mn shares at the end of Q2 2026, up 904.77K from the prior quarter and up 5.25Mn from a year earlier.
• BlackRock, Inc. held the largest position in CLPT at 2.38Mn shares as of June 30, 2026, or 7.80% of shares outstanding.
• The biggest increases in CLPT positions during Q2 2026 came from Mak Capital One LLC (+474.37K shares), BlackRock, Inc. (+297.05K shares), State Street Corp (+136.73K shares), Millennium Management LLC (+125.7K shares) and Susquehanna International Group, LLP (+104K shares).
• Among holders that kept a stake in ClearPoint Neuro, the biggest sellers in Q2 2026 were Goldman Sachs Group Inc (-324.71K shares), Massar Capital Management, LP (-156.69K shares), Deutsche Bank AG (-116.15K shares), Vanguard Portfolio Management LLC (-90.22K shares) and Aquatic Capital Management LLC (-87.81K shares).
• Per Business Quant data, the 10 largest holders of ClearPoint Neuro at the end of Q2 2026 were BlackRock, Inc. (2.38Mn shares), Mak Capital One LLC (2.38Mn shares), Vanguard Capital Management LLC (1.23Mn shares), State Street Corp (816.55K shares), Geode Capital Management, LLC (749.93K shares), Lane Generational LLC (444.83K shares), UBS Group AG (428.63K shares), Millennium Management LLC (357.68K shares), Brown Advisory Inc (325.91K shares) and Compass Financial Management LLC (295.68K shares).